Recombinant AhpC antigen from Mycobacterium bovis boosts BCG-primed immunity in mice
Ozgun F. Duzenli, Sezer Okay, İnci Kazkayası, Filiz Öner
TURKISH JOURNAL OF BIOLOGY · 2021-01
Abstract
. Vaccine antigen AhpC was formulated with Montanide ISA 61 VG, an oil-based emulsion adjuvant. Both IgG and IL-12 responses were observed in mice after administering the formulation both as a subunit vaccine alone and also as a booster vaccine for BCG immunization. However, a long-lasting response was observed when AhpC formulation was used as a booster (for BCG-primed immunization) as compared to being used as a subunit vaccine alone. In short, these findings suggested that AhpC has the potential to be used as a booster vaccine candidate for BCG-primed immunization.
MeSH terms
- Mycobacterium bovis
- Immunization
- Biology
- Vaccination
- Virology
- Adjuvant
- Booster dose
- Antigen
- BCG vaccine
- Microbiology
- Immunity
- Tuberculosis vaccines
- Recombinant DNA
- Mycobacterium tuberculosis
- Tuberculosis
- Immune system